Evidence map›Paper›PMID 36928172›Full record

ArticleJournal of the Pediatric Infectious Diseases Society2023

Monoclonal Antibody Use for Coronavirus Disease 2019 in Pediatric Patients: A Multicenter Retrospective Study.

Gilad Sherman, Gabriella S Lamb, Tanvi S Sharma, Elizabeth C Lloyd, Jerod Nagel, Nada N Dandam, Carlos R Oliveira, Hassan S Sheikha, Brenda I Anosike, Philip Lee and 7 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the Pediatric Infectious Diseases Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Effectiveness and Safety of Outpatient Monoclonal Antibody Use for the Treatment of COVID-19 in Children and Adolescents: Single Center Study.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2025
    Article
  3. Article
  4. Clinical Epidemiology of Pediatric Coronavirus Disease 2019 and its Postacute Sequelae.Seminars in respiratory and critical care medicine · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Gilad ShermanDivision of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
Gabriella S LambDivision of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
Tanvi S SharmaDivision of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
Elizabeth C LloydDepartment of Pediatrics, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Jerod NagelDepartment of Pharmacy, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Nada N DandamDepartment of Pharmacy, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Carlos R OliveiraDepartment of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0003-1897-6581
Hassan S SheikhaDepartment of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Brenda I AnosikeDepartment of Pediatrics, Children's Hospital at Montefiore, New York, New York, USA.
Philip LeeDepartment of Pediatrics, Children's Hospital at Montefiore, New York, New York, USA.ORCID 0000-0002-5039-3522
Surabhi B VoraDepartment of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, Washington, USA.
Karisma PatelDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Paul K SueDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.ORCID 0000-0002-9750-9107
Beenish RubbabDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
April M YarbroughDepartment of Pharmacy, Children's of Alabama, Birmingham, Alabama, USA.
Lakshmi GanapathiDivision of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
Mari M NakamuraDivision of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI RAJESH T GANDHI · 2004 to 2026
$94.4M
Clinical Epidemiology of Pediatric COVID-19 and MIS-CK23AI159518 · NIAID · YALE UNIVERSITY · PI OLIVEIRA, CARLOS RAFAEL · 2021 to 2024
$729k
NCATS NIH HHS UL1 TR001863NIAID NIH HHS K23 AI159518NIAID NIH HHS P30 AI060354NIH HHS K23AI159518
6 · The paper itself

Abstract

Monoclonal antibodies for COVID-19 are authorized in high-risk patients aged ≥12 years, but evidence in pediatric patients is limited. In our cohort of 142 patients treated at seven pediatric hospitals between 12/1/20 and 7/31/21, 9% developed adverse events, 6% were admitted for COVID-19 within 30 days, and none received ventilatory support or died.

Indexed as

COVID-19Antibodies, MonoclonalChildHospitalizationHospitals, PediatricHumansRetrospective StudiesAntibodies, Monoclonalbamlanivimab and etesevimabcasirivimab and imdevimabCOVID-19monoclonal antibodiespediatricSARS-CoV-2

Identifiers

PMID36928172
PMCPMC10112679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.